Contact Us: 1-888-667-3325 / customerservice@thedeal.com

Subscriber Content Preview | Request a free trialSearch  
  Go

Healthcare

Pot businesses in financial trouble face a hazy future

For the first time, an appellate court has weighed in on whether marijuana dispensaries are eligible for bankruptcy protection and if you're a debtor, the ruling is so not cool. Continue reading

Stock market volatility creates opportunities for merger arbs

Widening spreads offer bigger returns on slam-dunk deals and make risky transactions more attractive. The only worry is that financing might dry up. Continue reading

A&P sells pharmaceutical assets to Rite Aid

The Montvale, N.J., debtor wants to close the sale quickly so that customers can keep filling prescriptions. Continue reading

Small but dutiful: How to pursue change without filing

Activists with stakes below the 13D threshold can still wage successful campaigns. It's just a matter of building credibility among other shareholders. Continue reading

Nervy concentration: Health insurers cast aside caution

With consolidation already a concern, four of the five largest U.S. providers are getting together. Continue reading

FTC Commissioner Wright steps down

Surprise resignation leaves the agency leaning more Democratic. Continue reading

Difficulties with government payments play big role in healthcare companies' financial distress

A yet-to-be-released study on healthcare bankruptcies finds that middle-market providers are in the most danger and that acquirers should know most failures are due to more than any one thing. Continue reading

Halcyon Cabot accused of kickback scheme to hide discount in Cell Therapeutics PIPE

The investment bank is also accused of another kickback scheme that allegedly mislead investors in secondary market fund Felix Investments. Continue reading

Delaware appraisal and judicial activism

The Dell case raises the issue of how aggressive Delaware judges should be in shaping the state's law. Continue reading

Cardiac medical device M&A may not skip a beat

Following the $3.4 billion acquisition of Thoratec by St. Jude Medical, other cardiac medtech companies could prove attractive. Continue reading

Clinton attacks activist funds with an eye on corporate donors, Iowa diners

Hiking taxes on shorter investor holding periods and having activists disclose their stakes earlier comes right out of the Marty Lipton playbook and would be a boon to corporations Continue reading

Medical device company ViewRay raises $26.7M, goes public in reverse merger

The newly public company says it expects $70 million in revenues from business already booked. Continue reading

Meet the journalists

William Blair's Dan Shedivy sits down to talk M&A in the healthcare services sector

Middle Market healthcare deals stayed strong in 2014 but were relative ... Video

More Healthcare video

The Deal's Webcast Series

If you have not had the chance to enjoy our Webcast Series, now is the time. Join these free 60-minute discussions and get a handle on the latest strategies and tactics in private equity, cross-border and middle market dealmaking and more.

Industry Events

View information on all upcoming industry events which The Deal representatives are participating in.

The Deal Economy Event

Our senior journalists host the industry's leading forecasting event, where influential members of the deal community discuss the outlook for dealmaking.

The Deal on Twitter

Follow @TheDealNewsroom for the latest news across mergers and acquisitions, auctions, financings, restructurings and more!